Less than three months since it launched, the monkeypox rapid research response led by the University of Toronto’s Emerging and Pandemic Infections Consortium (EPIC) and three partner hospitals is generating results that could help curb transmission of the virus. Modelling work describes how to optimize the initial rollout of a limited vaccine supply to prevent the most infections while other studies focus on the risk of environmental transmission.